DPP4 and Parkinson disease: In recent years, several anti-diabetic drugs have been investigated in PD and AD patients, including metformin, glucagon like peptide (GLP-1) analogues, dipeptidyl peptidase 4 (DPP-4) inhibitors or gliptins, among others.